🇺🇸 FDA
Patent

US 11782065

Kits and methods for prediction and treatment of preeclampsia

granted A61KA61K35/16

Quick answer

US patent 11782065 (Kits and methods for prediction and treatment of preeclampsia) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K35/16